Octave Bioscience

Provider of AI-based molecular diagnostic tools for neurodegenerative diseases. The company has developed the first blood test to measure disease activity at the biology level. The platform will captures data using sensors, wearables & mobile tools to identify changes in disease status and optimize images adding quantitation, serial trends.